86 related articles for article (PubMed ID: 27956462)
1. Evaluation of neovascularization patterns in an orthotopic rat glioma model with dynamic contrast-enhanced MRI.
Xuesong D; Wei X; Heng L; Xiao C; Shunan W; Yu G; Weiguo Z
Acta Radiol; 2017 Sep; 58(9):1138-1146. PubMed ID: 27956462
[TBL] [Abstract][Full Text] [Related]
2. PDZK1 is correlated with DCE-MRI perfusion parameters in high-grade glioma.
Zhang Y; Wang F; Huang Y
Clinics (Sao Paulo); 2024; 79():100367. PubMed ID: 38692010
[TBL] [Abstract][Full Text] [Related]
3. Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging.
Boult JK; Borri M; Jury A; Popov S; Box G; Perryman L; Eccles SA; Jones C; Robinson SP
NMR Biomed; 2016 Nov; 29(11):1608-1617. PubMed ID: 27671990
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging assessment of residual tumor angiogenesis after insufficient microwave ablation and donafenib adjuvant therapy.
Ren Z; Feng G; Li B; Zhang C; Du Y
Sci Rep; 2024 Feb; 14(1):4557. PubMed ID: 38402352
[TBL] [Abstract][Full Text] [Related]
5. Long-term Intravital Investigation of an Orthotopic Glioma Mouse Model
Zheng K; Wang G; Zhou K; Wen X; Zhou Y; Ling S; Yang Q; Wu H; Xing J; Lin L; Zhao Q
In Vivo; 2024; 38(3):1192-1198. PubMed ID: 38688651
[TBL] [Abstract][Full Text] [Related]
6. The Consistence of Dynamic Contrast-Enhanced MRI and Filter-Exchange Imaging in Measuring Water Exchange Across the Blood-Brain Barrier in High-Grade Glioma.
Wang Z; Wang B; Li Z; Han G; Meng C; Jiao B; Guo K; Hsu YC; Sun Y; Liu Y; Bai R
J Magn Reson Imaging; 2023 Dec; 58(6):1850-1860. PubMed ID: 37021659
[TBL] [Abstract][Full Text] [Related]
7. Aberrant glioblastoma neovascularization patterns and their correlation with DCE-MRI-derived parameters following temozolomide and bevacizumab treatment.
Xue W; Du X; Wu H; Liu H; Xie T; Tong H; Chen X; Guo Y; Zhang W
Sci Rep; 2017 Oct; 7(1):13894. PubMed ID: 29066764
[TBL] [Abstract][Full Text] [Related]
8. Effects of Glutamine Synthetase on Neovascularization in Glioma: In Vivo MR Vessel Size Imaging and Histology.
Song T; Wang D; Zhang Y; Hao H; Li G; Ding X; Hu Z; Zhang Z; Liu Y; Wang H; Li X; Qian J
Curr Med Imaging; 2024; 20(1):e15734056287859. PubMed ID: 38544393
[TBL] [Abstract][Full Text] [Related]
9. DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin.
Sun X; Yang L; Yan X; Sun Y; Zhao D; Ji Y; Wang K; Chen X; Shen B
PLoS One; 2016; 11(9):e0162601. PubMed ID: 27632532
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast enhanced magnetic resonance imaging of an orthotopic pancreatic cancer mouse model.
Kim H; Samuel S; Totenhagen JW; Warren M; Sellers JC; Buchsbaum DJ
J Vis Exp; 2015 Apr; (98):. PubMed ID: 25938718
[TBL] [Abstract][Full Text] [Related]
11. Deuterium oxide as a contrast medium for real-time MRI-guided endovascular neurointervention.
Chen L; Liu J; Chu C; Han Z; Yadav N; Xu J; Bai R; Staedtke V; Pearl M; Walczak P; van Zijl P; Janowski M; Liu G
Theranostics; 2021; 11(13):6240-6250. PubMed ID: 33995656
[No Abstract] [Full Text] [Related]
12. In vivo MR imaging for tumor-associated initial neovascularization by supramolecular contrast agents.
Mahara A; Shima K; Soni R; Onishi R; Hirano Y; Saito S; Yamaoka T
Colloids Surf B Biointerfaces; 2023 Oct; 230():113525. PubMed ID: 37634287
[TBL] [Abstract][Full Text] [Related]
13. Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain.
Budde MD; Gold E; Jordan EK; Smith-Brown M; Frank JA
NMR Biomed; 2012 May; 25(5):726-36. PubMed ID: 21954124
[TBL] [Abstract][Full Text] [Related]
14. Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer.
Hormuth DA; Weis JA; Barnes SL; Miga MI; Quaranta V; Yankeelov TE
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1270-1279. PubMed ID: 29398129
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Tumor Angiogenesis: Dynamic Contrast-enhanced MR Imaging and Beyond.
Salem A; O'Connor JPB
Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):45-56. PubMed ID: 26613875
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced magnetic resonance imaging for monitoring neovascularization during bone regeneration-a randomized in vivo study in rabbits.
Righesso LAR; Terekhov M; Götz H; Ackermann M; Emrich T; Schreiber LM; Müller WEG; Jung J; Rojas JP; Al-Nawas B
Clin Oral Investig; 2021 Oct; 25(10):5843-5854. PubMed ID: 33786647
[TBL] [Abstract][Full Text] [Related]
17. The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment.
Türkbey B; Thomasson D; Pang Y; Bernardo M; Choyke PL
Diagn Interv Radiol; 2010 Sep; 16(3):186-92. PubMed ID: 19885783
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma.
Arevalo-Perez J; Trang A; Yllera-Contreras E; Yildirim O; Saha A; Young R; Lyo J; Peck KK; Holodny AI
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791921
[No Abstract] [Full Text] [Related]
19. Tumour status prediction by means of carbon-ion beam irradiation: comparison of washout rates between in-beam PET and DCE-MRI in rats.
Toramatsu C; Mohammadi A; Wakizaka H; Nitta N; Ikoma Y; Seki C; Kanno I; Yamaya T
Phys Med Biol; 2023 Sep; 68(19):. PubMed ID: 37625420
[No Abstract] [Full Text] [Related]
20. Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI.
Chang YC; Ackerstaff E; Tschudi Y; Jimenez B; Foltz W; Fisher C; Lilge L; Cho H; Carlin S; Gillies RJ; Balagurunathan Y; Yechieli RL; Subhawong T; Turkbey B; Pollack A; Stoyanova R
Sci Rep; 2017 Aug; 7(1):9746. PubMed ID: 28851989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
